From January 1, 2023 to March 31, 2023, the company has repurchased 309,012 shares, representing 1% for $0.48 million. With this, the company has completed the repurchase of 4,190,670 shares, representing 12.61% for $14.7 million under the buyback announced on March 15, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 USD | -.--% | -0.94% | -21.05% |
05-13 | HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating | MT |
05-09 | Transcript : Co-Diagnostics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.05% | 32.84M | |
-27.52% | 16.33B | |
-40.04% | 2.96B | |
+15.16% | 1.82B | |
-6.86% | 1.55B | |
+38.67% | 1.41B | |
-15.36% | 976M | |
+3.53% | 811M | |
-26.08% | 846M | |
+23.58% | 593M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.